Type II variation for application PMDA-2022-0083. Type II variation: New Dosage Strength for Cardilostat — routine update

Variation Number
PMDA-2022-0083-V483
Type
Type II
Application
Status
Failed
Fee
€44,573
Submitted
2024-02-04
Approved
—
Description

Type II variation: New Dosage Strength for Cardilostat — routine update